Correction to: Nature Reviews Nephrology https://doi.org/10.1038/s41581-023-00733-w, published online 3 July 2023.
In the originally published version of this article, the Competing interests section did not include “S.S. is a founder and scientific advisor of RegCell, which aims to develop a novel Treg cell-based therapy for autoimmune disease. S.S. and N.M. are holders of a patent for use of a CDK8/19 inhibitor in Treg cell production,” which is now amended in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mikami, N., Sakaguchi, S. Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation. Nat Rev Nephrol 19, 747 (2023). https://doi.org/10.1038/s41581-023-00768-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-023-00768-z
